Smoking status impacts treatment efficacy in smoke-induced lung inflammation: A pre-clinical study

Rationale: Smoking status and smoking history remain poorly accounted for as variables that could affect the efficacy of new drugs being tested in chronic obstructive pulmonary disease (COPD) patients. As a proof of concept, we used a pre-clinical model of cigarette smoke (CS) exposure to compare th...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Nadia Milad, Marie Pineault, Félix Tremblay, Joanie Routhier, Ariane Lechasseur, Marie-Josée Beaulieu, Sophie Aubin, Mathieu C. Morissette
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2022-09-01
Serija:	Frontiers in Pharmacology
Teme:	cigarette smoking COPD biologics monoclonal antibodies smoking status treatment timing
Online dostop:	https://www.frontiersin.org/articles/10.3389/fphar.2022.971238/full
Oznake:	Označite Brez oznak, prvi označite!